TipRanks
Markets have shown two themes in recent weeks, a combination of uncertainty and an upward trend. Day to day, its impossible to predict just what will happen, but the larger scale movement has been upwards. Looking ahead, all we know is that current events will reinforce the uncertainty.Earnings season has started. As the markets publicly traded companies report their Q3 results, well get a clearer idea as the nature of the economic recovery. Q1 was a disaster, the second quarter was better than expected; while Q3 is also expected to beat the expectations, no one will be surprised if it belly flops. So far, our first hint was the September jobs report, which fell short of the forecast but nevertheless showed some 661,000 new jobs last month.The big wild card, of course, is the national election, now just weeks away. President Trump is fighting for his political life and the Democrat opposition is fighting to regain control of the levers of government. Its an environment that practically screams for investors to take protective action for their portfolios. And its possible; even in an uncertain time, there are dividend stocks that promise reliable returns and risk mitigation. Using the TipRanks database, weve pulled two stocks with Strong Buy ratings and high dividend yields. Wall Streets analyst corps sees them as ripe for investment returns, while the dividend yield of 9% or better promises relief from todays low-rate regime. Hoegh LNG Partners (HMLP)Hoegh operates floating gas services, including storage facilities and regasification units that can act as LNG import terminals in the absence of shore-based infrastructure.Late this past summer, Hoegh announced a new CEO, part of a normal transition of leadership in the company. The remarkable aspect was that the transition occurred during the COVID outbreak and that the company showed positive revenues and earnings during that time, avoiding the heavy losses that have plagued some of its competitors. Hoeghs EPS has varied quarter to quarter over the past two years, but the Q2 numbers were in-line with the long-term average, and the Q3 outlook, to be reported next month, is in the same range.Steady earnings usually mean a steady dividend, and HMLP delivers. The company has a 6-year history of dividend reliability, and the payment, of 44 cents per common share, has been held stable through 2020. The $1.76 annualized payment gives an impressively high yield of 15.5%. This is more than 7x the average found among S&P listed dividend payers.Liam Burke, of B. Riley FBR, counts himself as a fan. He writes, Despite near-term decline in global LNG consumption caused by the coronavirus, there is solid underlying demand for LNG, which is estimated to grow by more than 3% to 5% annually until 2030, which sets the stage for consistent demand for high return floating storage and re-gasification units (FSRU) beyond current contract periods. We continue to believe in the long-term strength of the LNG market and HMLP's underlying charters despite the inherent counter-party risks created by a near-term decline in LNG consumption related to COVID-19.Burke rates HMLP shares a Buy, and his $17 price target indicates confidence in a 45.5% upside potential. (To watch Burkes track record, click here)Overall, Wall Street has given HMLP 3 Buys and 1 Hold recently, for a Strong Buy consensus rating. The average price target is $13.67, suggesting a 19% upside from the current trading level of $11.41. (See HMLP stock analysis on TipRanks)Hess Midstream Operations (HESM)Next up on todays list of dividend champs is Hess Midstream, a player in the US oil and gas industry. Hess provides infrastructure services for gathering, processing, storing, and transporting both crude oil and natural gas products in the Bakken formation of North Dakota.Production companies have kept the product flowing despite the coronavirus, which is one reason for the low prices in the oil markets but it has also kept the midstreamers in demand. Hess has benefited from the continuing need for its technical knowledge of pipeline network, and the result has been that, while much of the oil industry had to retrench recently, Hess saw only modest losses in revenues while earnings remained in-line with their 2-year recent history. Second Quarter EPS was 29 cents; that was lower than Q1, but higher than 4Q19.Hess has turned its steady earnings to shareholders advantage, with a dividend that has been increased every quarter for the past 2 years. The last payment, sent in August, was 44 cents per common share. This gave a yield of 9.86%, strong by any standard.JPMorgan analyst Tarek Hamid says of Hess, The unique pricing model underpinning core profitability remains unmatched and further helps to eliminate (to an extent) DAPL uncertainty overhang relative to peers. Longer-term growth prospects could come in the form of asset level acquisitions and potentially a framework tied to Hesss GOM position, but management has conveyed a conservative approach with respect to corporate M&A HESM will burn cash this year, though our modeling indicates a flip to FCF generation in FY21 on lower capital intensity and higher y/y profitability.To this end, JPMorgan rates HESM an Overweight (i.e. Buy) along with a $23 price target. This figure suggests a 40% upside for HESM shares in the months ahead.Overall, this stocks Strong Buy consensus rating is supported by 4 Buys and 1 Hold. Shares are selling for $16.46, and the average price target of $19.75 indicates a 20% upside potential. (See HESM stock analysis on TipRanks)To find good ideas for dividend stocks trading at attractive valuations, visit TipRanks Best Stocks to Buy, a newly launched tool that unites all of TipRanks equity insights.Disclaimer: The opinions expressed in this article are solely those of the featured analysts. The content is intended to be used for informational purposes only. It is very important to do your own analysis before making any investment.
Read more here:
What to expect from the FDA's COVID-19 vaccine meeting today - Yahoo Finance
- Covid-19 diagnostic based on MIT technology might be tested on patient samples soon - The MIT Tech [Last Updated On: March 16th, 2020] [Originally Added On: March 16th, 2020]
- Dutch researchers first to find Covid-19 antibodies: Report - NL Times [Last Updated On: March 16th, 2020] [Originally Added On: March 16th, 2020]
- Getting Viral: Why COVID-19 is Such a Threat to the 60+ Plus Population and Why the Response May Make It Worse - CounterPunch [Last Updated On: March 16th, 2020] [Originally Added On: March 16th, 2020]
- U.K. Scientists Paying People $4,000 to Get Infected with Coronaviruses - Newsweek [Last Updated On: March 16th, 2020] [Originally Added On: March 16th, 2020]
- Youre Likely to Get the Coronavirus - The Atlantic [Last Updated On: March 16th, 2020] [Originally Added On: March 16th, 2020]
- Mountain West Scientists Contributing To The Race For A COVID-19 Vaccine - KUNC [Last Updated On: March 16th, 2020] [Originally Added On: March 16th, 2020]
- China Threatens to Withhold COVID-19 Vaccine - The - The Floridian [Last Updated On: March 16th, 2020] [Originally Added On: March 16th, 2020]
- Look for novel coronavirus treatments first, experts say, and vaccines are further off than you think - FiercePharma [Last Updated On: March 16th, 2020] [Originally Added On: March 16th, 2020]
- COVID-19 vaccine will take at least two years to develop: health officials - The Hindu [Last Updated On: March 16th, 2020] [Originally Added On: March 16th, 2020]
- 'Where's the money?' Inside GeoVax, one lab working to create a COVID-19 vaccine - wgxa.tv [Last Updated On: March 16th, 2020] [Originally Added On: March 16th, 2020]
- Homeland Security News Wire: COVID-19 Virus Isolated Better Testing, Treatments, Vaccines Are Near - Los Alamos Daily Post [Last Updated On: March 16th, 2020] [Originally Added On: March 16th, 2020]
- With the coronavirus, drug that once raised global hopes gets another shot - STAT [Last Updated On: March 16th, 2020] [Originally Added On: March 16th, 2020]
- Farmington biotech teams with Yale to pursue COVID-19 vaccine - Hartford Business [Last Updated On: March 16th, 2020] [Originally Added On: March 16th, 2020]
- Father and daughter virologists working on vaccine for COVID-19 - National Observer [Last Updated On: March 16th, 2020] [Originally Added On: March 16th, 2020]
- Sanofi exploring possibility of COVID-19 vaccine that would be produced in Pa. - Bucks County Courier Times [Last Updated On: March 16th, 2020] [Originally Added On: March 16th, 2020]
- EMA offers free advice to COVID-19 vaccine and therapeutic developers - European Pharmaceutical Review [Last Updated On: March 16th, 2020] [Originally Added On: March 16th, 2020]
- Italy COVID-19 total tops 10000; funding grows for treatments, vaccines - CIDRAP [Last Updated On: March 16th, 2020] [Originally Added On: March 16th, 2020]
- Free Tests, Free Vaccines: Remove the Wealth Barriers to Fighting COVID-19 - The Nation [Last Updated On: March 16th, 2020] [Originally Added On: March 16th, 2020]
- Inovio Pharm gets $5M from Gates Foundation to further COVID-19 vaccine project - The San Diego Union-Tribune [Last Updated On: March 16th, 2020] [Originally Added On: March 16th, 2020]
- On the hunt for a Covid-19 vaccine - Vantage [Last Updated On: March 16th, 2020] [Originally Added On: March 16th, 2020]
- When will a coronavirus vaccine be ready? - The Guardian [Last Updated On: March 16th, 2020] [Originally Added On: March 16th, 2020]
- Coronavirus vaccine: why will it take so long to create? - Los Angeles Times [Last Updated On: March 16th, 2020] [Originally Added On: March 16th, 2020]
- Covid-19 vaccine in development by J&J and BIDMC. - Pharmaceutical Technology [Last Updated On: March 16th, 2020] [Originally Added On: March 16th, 2020]
- First COVID-19 vaccine trial starts Monday in Seattle, government official says - KOMO News [Last Updated On: March 16th, 2020] [Originally Added On: March 16th, 2020]
- Others at Kansas home tied to COVID-19 death tested negative - hays Post [Last Updated On: March 17th, 2020] [Originally Added On: March 17th, 2020]
- Commentary: Is the UK's herd immunity strategy to combat COVID-19 worth pursuing? - CNA [Last Updated On: March 17th, 2020] [Originally Added On: March 17th, 2020]
- 5 Promising Covid-19 Vaccines and Drugs That Could End Coronavirus Pandemic - Observer [Last Updated On: March 17th, 2020] [Originally Added On: March 17th, 2020]
- First human trial of COVID-19 vaccine gets under way in the US - EWN [Last Updated On: March 17th, 2020] [Originally Added On: March 17th, 2020]
- Government official: First dose to be delivered Monday in clinical trial for potential COVID-19 vaccine - Associated Press [Last Updated On: March 17th, 2020] [Originally Added On: March 17th, 2020]
- First stage of COVID-19 vaccine testing gets under way - The Mercury News [Last Updated On: March 17th, 2020] [Originally Added On: March 17th, 2020]
- The Race Is On To Find A Vaccine For COVID-19 - WCCO | CBS Minnesota [Last Updated On: March 17th, 2020] [Originally Added On: March 17th, 2020]
- 10 Positive Updates on the COVID-19 Outbreaks From Around the World - Good News Network [Last Updated On: March 17th, 2020] [Originally Added On: March 17th, 2020]
- Authorities warn of scam callers seeking sensitive information to reserve a vaccine for COVID-19 - FOX 13 Tampa Bay [Last Updated On: March 17th, 2020] [Originally Added On: March 17th, 2020]
- COVID-19 Vaccine Still on Phase 1 and Might Take 18 Months From Now to Create Says Global Health Official - Tech Times [Last Updated On: March 17th, 2020] [Originally Added On: March 17th, 2020]
- Army command continues work on COVID-19 vaccine, treatment | Hospital near Fort Detrick to setup drive-through testing site - WUSA9.com [Last Updated On: March 17th, 2020] [Originally Added On: March 17th, 2020]
- Australian researchers have made an important discovery in the race to find a COVID-19 vaccine - SBS News [Last Updated On: March 17th, 2020] [Originally Added On: March 17th, 2020]
- Regeneron aims to have coronavirus antibody treatment ready for human testing by early summer - CNBC [Last Updated On: March 17th, 2020] [Originally Added On: March 17th, 2020]
- Covid-19 outbreak: the key to quicker vaccine development - Pharmaceutical Technology [Last Updated On: March 17th, 2020] [Originally Added On: March 17th, 2020]
- COVID-19 Vaccine Test Begins With U.S. Volunteer | Time [Last Updated On: March 17th, 2020] [Originally Added On: March 17th, 2020]
- The FDA Regulatory Landscape for Covid-19 Treatments and Vaccines - JD Supra [Last Updated On: March 18th, 2020] [Originally Added On: March 18th, 2020]
- Montgomery Co. life science companies work together on COVID-19 vaccine - WDVM 25 [Last Updated On: March 18th, 2020] [Originally Added On: March 18th, 2020]
- Meet the volunteers testing the new experimental COVID-19 vaccine - CTV News [Last Updated On: March 18th, 2020] [Originally Added On: March 18th, 2020]
- The U.S. Should Make COVID-19 Testing, Prevention And Care Free To All - WBUR [Last Updated On: March 18th, 2020] [Originally Added On: March 18th, 2020]
- Biotech That Doubled on Covid-19 Frenzy Readies New Flu Vaccine - Bloomberg [Last Updated On: March 18th, 2020] [Originally Added On: March 18th, 2020]
- Jones sponsors bill for insurance plans to cover COVID-19 vaccines when they're available - alreporter.com [Last Updated On: March 18th, 2020] [Originally Added On: March 18th, 2020]
- Seattle volunteers receive world's first experimental COVID-19 vaccine - KOMO News [Last Updated On: March 18th, 2020] [Originally Added On: March 18th, 2020]
- What scientists are working on to find a cure for coronavirus COVID-19 - ABC News [Last Updated On: March 21st, 2020] [Originally Added On: March 21st, 2020]
- This study shows how difficult it will be to find Covid-19 vaccine volunteers - Ladders [Last Updated On: March 21st, 2020] [Originally Added On: March 21st, 2020]
- Differences between COVID-19 and flu? We have no immunity or vaccine for the new virus, local expert says - WFTV Orlando [Last Updated On: March 21st, 2020] [Originally Added On: March 21st, 2020]
- GeekWire Podcast: Bill Gates on COVID-19, gig workers in peril, and more on the coronavirus crisis - GeekWire [Last Updated On: March 21st, 2020] [Originally Added On: March 21st, 2020]
- Coronavirus vaccine: Expert warns that a usable Covid-19 vaccination won't be available for at least a year - inews [Last Updated On: March 21st, 2020] [Originally Added On: March 21st, 2020]
- COVID-19 Is Deadlier Than The Flu. How Else Do They Differ? : Goats and Soda - NPR [Last Updated On: March 21st, 2020] [Originally Added On: March 21st, 2020]
- Is This 'Good News' List About the COVID-19 Pandemic Accurate? - Snopes.com [Last Updated On: March 21st, 2020] [Originally Added On: March 21st, 2020]
- WHO expert: Finding and distributing COVID-19 vaccine in 18 months would be 'historic' - EURACTIV [Last Updated On: March 21st, 2020] [Originally Added On: March 21st, 2020]
- COVID-19: 5 reasons to be cautiously hopeful - Medical News Today [Last Updated On: March 21st, 2020] [Originally Added On: March 21st, 2020]
- Scammers are trying to trick people into reserving a COVID-19 vaccine over the phone - The Verge [Last Updated On: March 21st, 2020] [Originally Added On: March 21st, 2020]
- Coronavirus: How scientists are racing to find a Covid-19 vaccine - ITV News [Last Updated On: March 21st, 2020] [Originally Added On: March 21st, 2020]
- COVID-19 Vaccines Are Coming, but Theyre Not What You Think - The Atlantic [Last Updated On: March 21st, 2020] [Originally Added On: March 21st, 2020]
- First patients injected with potential COVID-19 vaccine in ... [Last Updated On: March 21st, 2020] [Originally Added On: March 21st, 2020]
- COVID-19 vaccine - Wikipedia [Last Updated On: March 21st, 2020] [Originally Added On: March 21st, 2020]
- Researchers working to fast-track a COVID-19 vaccine - FOX 9 [Last Updated On: March 23rd, 2020] [Originally Added On: March 23rd, 2020]
- Projects awarded 10.5m to boost Covid-19 vaccine research - National Health Executive [Last Updated On: March 23rd, 2020] [Originally Added On: March 23rd, 2020]
- CureVac denies reports that Trump admin sought to acquire Covid-19 vaccine rights - MedCity News [Last Updated On: March 23rd, 2020] [Originally Added On: March 23rd, 2020]
- Cork workers to be involved in race to find vaccine for Covid-19 - Echo Live [Last Updated On: March 23rd, 2020] [Originally Added On: March 23rd, 2020]
- COVID-19 Drugs And Vaccines Showing Promise - WVXU [Last Updated On: March 23rd, 2020] [Originally Added On: March 23rd, 2020]
- Moderna could make experimental COVID-19 vaccine available to healthcare workers by fall - TechCrunch [Last Updated On: March 23rd, 2020] [Originally Added On: March 23rd, 2020]
- Beware of Fraudulent Coronavirus Tests, Vaccines and Treatments - WBIW.com [Last Updated On: March 25th, 2020] [Originally Added On: March 25th, 2020]
- Singapore scientists plan to start testing COVID-19 vaccine this year: Gan Kim Yong - CNA [Last Updated On: March 25th, 2020] [Originally Added On: March 25th, 2020]
- Meet the scientists contributing to race for COVID-19 vaccine - Study International News [Last Updated On: March 25th, 2020] [Originally Added On: March 25th, 2020]
- The Covid-19 Vaccine: How Much Will It Cost & Who Will Have Access? - KALW [Last Updated On: March 25th, 2020] [Originally Added On: March 25th, 2020]
- Scientists race to find COVID-19 vaccine, as global cases of infection climb - Yahoo Finance [Last Updated On: March 25th, 2020] [Originally Added On: March 25th, 2020]
- Dynavax and Clover Biopharmaceuticals Announce Research Collaboration to Evaluate Coronavirus (COVID-19) Vaccine Candidate with CpG 1018 Adjuvant -... [Last Updated On: March 25th, 2020] [Originally Added On: March 25th, 2020]
- Soligenix Inc. Heat-Stabilization Platform Evaluating Use With COVID-19 Vaccine; Zacks Small-Cap Research Increases Valuation To $12.00 Per Share -... [Last Updated On: March 25th, 2020] [Originally Added On: March 25th, 2020]
- Inovio Pharmaceuticals Gets Help From Ology Bioservices and the Defense Department with Its COVID-19 Vaccine Candidate - The Motley Fool [Last Updated On: March 25th, 2020] [Originally Added On: March 25th, 2020]
- New coronavirus research suggests vaccines developed to treat it could be long-lasting - TechCrunch [Last Updated On: March 25th, 2020] [Originally Added On: March 25th, 2020]
- Hoth Surges on Collaboration With Voltron for COVID-19 Vaccine - Yahoo Finance [Last Updated On: March 25th, 2020] [Originally Added On: March 25th, 2020]
- UVM Researcher Offers Insights on Vaccines and COVID-19 - Seven Days [Last Updated On: March 27th, 2020] [Originally Added On: March 27th, 2020]
- 20 Indian institutes working to find Covid-19 vaccine, IITs focused on portable ventilators - ThePrint [Last Updated On: March 27th, 2020] [Originally Added On: March 27th, 2020]
- Researchers in Pittsburgh, Paris and Vienna Win Grant for COVID-19 Vaccine - UPJ Athletics [Last Updated On: March 27th, 2020] [Originally Added On: March 27th, 2020]
- Research Team in Race to Develop COVID-19 Vaccine and Treatments - USC Viterbi School of Engineering [Last Updated On: March 27th, 2020] [Originally Added On: March 27th, 2020]